Muscle Growth
A secretagogue and recombinant GH pen, paired for growth research.
Part of our Growth & Recovery.
related stacksbundle & save
Advanced Growth Stack
Nightly secretagogue pulses layered with recombinant GH.
CJC-1295 + Ipamorelin 20
Somatropin 100 Muscle Growth Research Stack | Veyvora
Before sourcing muscle growth peptides for in-vitro research, verify these five points:
- Bundle identity: confirm the exact pen names, quantities and formulations listed on the current catalogue page
- Batch documentation: request the certificate of analysis (COA) for the specific lot number before accepting delivery
- Evidence boundary: check that any biological rationale cited applies to the individual compounds, not the commercial bundle as a whole
- Regulatory status: the Medicines and Healthcare products Regulatory Agency (MHRA) determines medicinal classification case by case; “research use only” labelling does not automatically exempt a product [5]
- Price and availability: take the live GBP figure and stock status from the current offer block at checkout, not from third-party listings
Veyvora’s Muscle Growth bundle is a two-pen stack comprising Tesamorelin 20 and Somatropin 100, listed as a bundle & save offer with a stated 12% saving on the Veyvora growth-category page as of 30 August 2026 [3]. The bundle is described as “a secretagogue and recombinant GH pen, paired for growth research” and is supplied strictly for in-vitro laboratory research use only [1].
This page covers: (1) exactly what the bundle contains and how each pen is specified; (2) where the evidence boundary sits between individual-compound literature and bundle-level claims; and (3) what UK regulatory context applies before procurement.
Check the live bundle price and stock now, go directly to the Muscle Growth stack offer block on the Veyvora product page.
| Detail | Value (as of 30 August 2026) |
|---|---|
| Bundle name | Muscle Growth Stack |
| Components | Tesamorelin 20 + Somatropin 100 |
| Format | Two × 3 mL multi-dose research pens |
| Stated saving | 12% versus individual pen prices |
| Live GBP price | See current offer block at checkout [3] |
| Stock status | See current offer block at checkout [3] |
| Intended use | In-vitro laboratory research only |
No specific GBP bundle price or live stock count was confirmed in the reviewed pages; both figures must be taken from the live checkout at the time of order [3].
Key Takeaways
- The Muscle Growth Stack pairs Tesamorelin 20 (a GHRH-analogue secretagogue) with Somatropin 100 (recombinant human GH), each supplied as a 3 mL, 300-click multi-dose research pen.
- The two compounds address distinct mechanistic roles: Tesamorelin stimulates pituitary GH release; Somatropin delivers the recombinant-GH signal directly, bypassing pituitary mediation.
- Published literature covers each compound individually; no bundle-specific biological outcome data appears on the reviewed Veyvora pages as of 30 August 2026.
- Both pens carry separate batch COAs available on request; neither pen is classified as a medicine by Veyvora, and MHRA classification depends on presentation and intended use assessed case by case.
- Live GBP price and stock status must be confirmed at checkout before ordering.
Muscle Growth Research Stack: exact bundle identity
Confirm these details against the live product page before sourcing:
- Exact bundle name: Muscle Growth Stack (listed under Veyvora’s growth category as of 30 August 2026) [3]
- Component one: Tesamorelin 20, a growth-hormone-releasing-hormone (GHRH) analogue pen, 20 mg per unit, 67 µg per click [1]
- Component two: Somatropin 100, recombinant human growth hormone (GH), 100 IU per unit, 0.33 IU per click [2]
- Format: Two × 3 mL, 300-click multi-dose research pens, each supplied with 10 × 31G · 6 mm pen needles and a dosing card [1][2]
- Stated saving: 12% versus individual pen prices, shown as a bundle & save offer on the growth-category page [3]
- Live GBP price and stock: take both figures from the current offer block at checkout; no specific price was confirmed in the reviewed pages [3]
Veyvora describes the Muscle Growth Stack as “a secretagogue and recombinant GH pen, paired for growth research,” supplied strictly for in-vitro laboratory research use only [1][3]. Once an order arrives, verify your batch against its COA by matching the lot number on the pen to the published certificate before any laboratory use.
Included components
The Muscle Growth Research Stack contains two pens, Tesamorelin 20, a GHRH analogue, and Somatropin 100, recombinant human GH, each addressing a distinct point in the growth axis [1][2].
| Attribute | Tesamorelin 20 | Somatropin 100 |
|---|---|---|
| Compound class | GHRH analogue (secretagogue) | Recombinant human GH |
| Strength per unit | 20 mg | 100 IU |
| Dose per click | 67 µg | 0.33 IU |
| Format | 1 × 3 mL, 300-click multi-dose pen | 1 × 3 mL, 300-click multi-dose pen |
| Needles supplied | 10 × 31G · 6 mm pen needles | 10 × 31G · 6 mm pen needles |
| Dosing card | Included | Included |
| COA | Available on request against batch number | Available on request against batch number |
| Product page | Tesamorelin 20 | Confirm via live catalogue [2] |
All values above are drawn from Veyvora’s component pages as of 30 August 2026 [1][2]. Any attribute not shown in the table, including current GBP unit price and live stock count, should be confirmed against the current offer block before ordering.
Tesamorelin acts at the secretagogue level by stimulating the pituitary to release endogenous GH, whereas Somatropin delivers the recombinant-GH signal directly without requiring pituitary mediation. That mechanistic distinction matters when designing a growth-axis protocol. Researchers evaluating the secretagogue component against single-compound alternatives may find the CJC-1295 versus Ipamorelin comparison useful before finalising their protocol. For post-receipt handling, consult Veyvora’s storage and stability guidance to maintain material integrity at the stated storage temperature.
Bundle-level evidence boundary
Published mechanistic literature covers Tesamorelin and Somatropin individually; that body of evidence does not establish a combined effect for the bundle as a whole, so any assertion about what the paired stack produces in a biological system requires independent experimental evidence [1][2].
Veyvora’s product documentation describes the pairing as “a secretagogue and recombinant GH pen, paired for growth research,” which is a formulation rationale rather than an efficacy claim [1]. No bundle-specific biological outcome data appears on the reviewed catalogue pages as of 30 August 2026 [3].
The distinction matters for protocol design:
- Tesamorelin 20 is a GHRH-analogue research pen; published mechanistic literature covers the secretagogue class, not this commercial pairing [1].
- Somatropin 100 is a recombinant-GH research pen; its compound-level literature is separate from any stack-level claim [2].
- Veyvora states both compounds are supplied strictly for in-vitro laboratory research and are not medicines [1][3].
- No bundle-specific COA exists; each pen carries its own batch COA, available on request against the individual batch number [1][2].
Laboratories whose protocol does not require a paired growth-axis format can compare alternatives across the Growth & Recovery Research Pens catalogue. Those whose work concerns repair rather than growth-focused research should consult the repair and recovery research pens category before committing to this stack.
Batch Documents and Handling
Every pen in the Muscle Growth Research Stack ships with a batch-specific COA available on request against the individual batch number [1][2]. The COA is not published as a downloadable file on the reviewed catalogue pages as of 30 August 2026; its existence is verified, but the exact batch contents remain unverified without the specific lot document [1].
Certificate of Analysis
Each pen carries its own COA rather than a shared bundle document. To confirm compound identity, purity, and endotoxin status before laboratory use, verify your batch against its COA using the batch number printed on the pen.
Cold-Chain Dispatch
Veyvora states that both Tesamorelin 20 and Somatropin 100 ship cold within 24 hours of order confirmation [1][2]. Packaging specification and carrier identity do not appear on the reviewed pages; confirm those specifics with Veyvora directly before committing to a time-sensitive protocol.
Researchers whose work requires a different storage or stability profile should review the MOTS-c and SS-31 comparison for an alternative research domain with separately documented handling requirements.
Commercial Terms
The Muscle Growth Research Stack is listed as a bundle-and-save offer with a stated saving of 12% against the combined individual-pen prices [1][3]. No specific GBP bundle price, stock count, or per-order delivery fee appears on the reviewed catalogue pages as of 30 August 2026; see the live product page and confirm those figures at checkout before committing to a purchase [1][3].
What Is Confirmed
- Bundle saving: 12% off the combined component price, as stated on the Veyvora stacks page [3]
- Dispatch: both pens stated to ship cold within 24 hours of order confirmation [1][3]
- Currency display: Veyvora states prices are shown in the user’s selected currency; GBP display is available but no specific bundle figure is confirmed here [1]
Researchers who want to understand what the purity figure on the COA actually demonstrates before finalising an order should review what HPLC purity does and does not prove. Cold-chain requirements after delivery are covered in the storage and stability guidance.
Research-Use-Only Limitations
Veyvora supplies both pens in the Muscle Growth Research Stack strictly for in-vitro and laboratory research; neither Tesamorelin 20 nor Somatropin 100 is classified as a medicine by Veyvora, and neither is offered for human or veterinary consumption [1][3].
What UK Regulatory Context Requires Researchers to Understand
The MHRA determines whether a product constitutes a medicine on a case-by-case basis, assessing presentation and intended use rather than accepting supplier labelling at face value. Published MHRA guidance confirms that “research use only” labelling does not, by itself, exempt a product from medicines regulation where its presentation or intended use brings it within the definition of a medicinal product [5].
Scope Boundary for This Stack
Researchers sourcing the Muscle Growth Research Stack should apply the following scope limits before procurement:
- Intended use: in-vitro and laboratory research only; no human or veterinary administration [1][3]
- Regulatory status: not classified as a medicine by Veyvora, but MHRA classification depends on presentation and intended use, assessed case by case [5]
- Outcome claims: no bundle-level efficacy data for muscle growth is published on the reviewed Veyvora pages; any biological outcome claim requires independent peer-reviewed evidence on the individual compounds, not the commercial pairing [1][3]
- COA scope: batch documents confirm assay purity for the supplied lot and do not constitute clinical or safety data for human use [1][4]
Researchers evaluating the secretagogue component in isolation, or considering a single-compound alternative, can review the CJC-1295 versus Ipamorelin comparison before finalising a procurement decision. The Growth & Recovery Research Pens catalogue lists current options with their component specifications for those comparing the Muscle Growth stack against other verified formats in the same category [3].
To confirm the live bundle price, current stock, and batch COA availability for your specific order, go directly to the Muscle Growth stack offer block on the Veyvora product page now.
Sources
[1] Tesamorelin 20 mg Pen | Veyvora, veyvora.com, https://veyvora.com/peptides/tesamorelin-20 [2] Somatropin 100 IU Pen | Veyvora, veyvora.com, https://veyvora.com/peptides/somatropin-100 [3] Growth & Recovery Research Pens | Veyvora, veyvora.com, https://veyvora.com/categories/growth [4] How to read a COA | Veyvora, veyvora.com, https://veyvora.com/testing/how-to-read-a-coa [5] Borderline products: how to tell if your product is a medicine - GOV.UK, gov.uk, 2026, https://www.gov.uk/guidance/borderline-products-how-to-tell-if-your-product-is-a-medicine

